Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TADAWUL/9574 stock hub

TADAWUL/9574 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TADAWUL/9574is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

332.5M

Saudi Stock Exchange

Market data

Price

Recent price action with selectable time range.

TADAWUL/9574TADAWUL/9574

—

Loading chart…

In the news

Latest news · TADAWUL/9574

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E8

P25 n/aP50 n/aP75 n/a

ROE31.7

P25 n/aP50 n/aP75 n/a

ROIC20.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TADAWUL/9574 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

207

Groups with data

Currency

SAR

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Saudi Arabia
Country code	SA
Employees	100
Enterprise value	SAR 454.4M
Exchange	Saudi Stock Exchange
Financial currency	SAR
First seen	2026-05-10
Industry	Medical Devices
Isin	SA15RH24LJ13
Last refreshed	2026-05-10
Market cap	SAR 332.5M
Price	SAR 96.15
Price currency	SAR
Rev Per Employee	4,187,787.78x
Sector	Healthcare
Sic	5047
Symbol	tadawul/9574
Website	https://promedex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	12.54%
EV Earnings	10.89x
EV/EBIT	7.6x
EV/EBITDA	6.64x
EV/FCF	-19.32x
EV/Sales	1.08x
FCF yield	-7.07%
P/B ratio	2.21x
P/E ratio	7.97x
P/S ratio	0.79x
PE Ratio3 Y	9.56x
PE Ratio5 Y	9.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.27%
EBITDA Margin	15.77%
Gross margin	44.17%
Gross Profit	SAR 185M
Gross Profit Growth	14.72%
Gross Profit Growth Q	31.14%
Gross Profit Growth3 Y	15.02%
Gross Profit Growth5 Y	12.55%
Net Income	SAR 41.7M
Net Income Growth	50.84%
Net Income Growth Q	26.12%
Net Income Growth Quarters	4%
Net Income Growth Years	3%
Net Income Growth3 Y	14.49%
Net Income Growth5 Y	12.64%
Pretax Margin	10.91%
Profit Margin	9.96%
Profit Per Employee	SAR 417,076
Profitable Years	6
ROA	10.05
Roa5y	9.34
ROCE	35.58
ROE	31.66
Roe5y	37.11
ROIC	20.06
Roic5y	25.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	2.4%
EPS Growth	50.84
EPS Growth Q	26.12
EPS Growth Quarters	4
EPS Growth Years	3
EPS Growth3 Y	14.49
EPS Growth5 Y	12.73
OCF Growth3 Y	-42.58%
OCF Growth5 Y	-43.46%
Revenue Growth	33.72x
Revenue Growth Q	37.98x
Revenue Growth Quarters	9x
Revenue Growth Years	5x
Revenue Growth3 Y	14.54x
Revenue Growth5 Y	13.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SAR 1.13
Assets	SAR 422.6M
Cash	SAR 3.8M
Current Assets	SAR 394.4M
Current Liabilities	SAR 254.6M
Debt	SAR 125.7M
Debt EBITDA	SAR 1.84
Debt Equity	SAR 0.84
Debt FCF	SAR -5.35
Equity	SAR 150.2M
Interest Coverage	5.15
Liabilities	SAR 272.4M
Long Term Assets	SAR 28.2M
Long Term Liabilities	SAR 17.8M
Net Cash	SAR -121.9M
Net Cash By Market Cap	SAR -36.66
Net Debt EBITDA	SAR 1.85
Net Debt Equity	SAR 0.81
Tangible Book Value	SAR 150.2M
Tangible Book Value Per Share	SAR 42.92
WACC	5.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.55
Inventory Turnover	1.57
Net Working Capital	SAR 260.1M
Quick ratio	0.9
Working Capital	SAR 139.8M
Working Capital Turnover	SAR 3.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	SAR 1
Dividend Years	2
Dividend Yield	1.04%
Last Dividend	SAR 1
Payout Ratio	8.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	2.4%
200-day SMA	91.74
50-day SMA	98.99
50-day SMA vs 200-day SMA	50over200
All Time High	115
All Time High Change	-16.39%
All Time High Date	2025-04-03
All Time Low	63.54
All Time Low Change	51.32%
All Time Low Date	2023-10-09
ATR	1.19
Beta	-0.05
Beta1y	-0
Beta2y	-0.04
Ch YTD	-0.88
High	98
High52	107
High52 Date	2026-03-29
High52ch	-10.14%
Low	96.1
Low52	75
Low52 Date	2025-08-13
Low52ch	28.2%
Ma50ch	-2.87%
Price vs 200-day SMA	4.8%
RSI	38.19
RSI Monthly	55.02
RSI Weekly	0
Sharpe ratio	0.16x
Sortino ratio	0.41
Total Return	1.04%
Tr YTD	-0.88
Tr1m	-3.27%
Tr1w	-1.89%
Tr3m	-4.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SAR 59.8M
Operating Income Growth	21.68
Operating Income Growth Q	48.38
Operating Income Growth3 Y	18.07
Operating Income Growth5 Y	13.85
Operating margin	14.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,010,189%
Net Borrowing	28,478,715
Shares Insiders	14.24%
Shares Out	3,500,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SAR -23.5M
Average Volume	567.3x
Bv Per Share	42.92
CAPEX	SAR -24.2M
Ch1m	-3.27
Ch1w	-1.89
Ch1y	1.21
Ch3m	-4.42
Ch6m	13.18
Change	-0.98%
Change From Open	-1.89
Close	97.1
Days Gap	0.93
Depreciation Amortization	6,267,968
Dollar Volume	19,230
Earnings Date	2026-06-02
EBIT	SAR 59.8M
EBITDA	SAR 66M
EPS	SAR 11.92
F Score	5
FCF	SAR -23.5M
FCF EV Yield	-5.18x
FCF Per Share	SAR -6.72
Financing CF	14,048,149
Fiscal Year End	December
Founded	2,010
Graham Number	107.26959
Graham Upside	11.56
Income Tax	SAR 4M
Investing CF	-15,806,918
Is Primary Listing	1
Last Earnings Date	2025-12-03
Last Report Date	2025-12-31
Lynch Fair Value	SAR 151
Lynch Upside	56.69
Ma150	94
Ma150ch	2.29%
Ma20	98.78
Ma20ch	-2.66%
Net CF	-1,043,479
Next Earnings Date	2026-06-02
Open	98
P OCF Ratio	464.8
Payment Date	2025-07-06
Position In Range	2.63
Ppne	28,227,897
Price Date	2026-05-07
Price EBITDA	SAR 5.03
Ptbv Ratio	2.21
Relative Volume	0.35x
Revenue	418,778,778x
Tax By Revenue	0.95x
Tax Rate	8.7%
Tr6m	13.18%
Volume	200
Z Score	2.93

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TADAWUL/9574 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$1.00 annual per share

Payout ratio

+8.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+1.0%

Dividend yield + buyback yield combined

Performance

TADAWUL/9574 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TADAWUL/9574?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+14.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TADAWUL/9574 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.2

Neutral momentum band

Price vs 200-day MA

+4.8%

50/200-day relationship not available

Beta (5Y)

-0.05

Less volatile than the market

Sharpe ratio

0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TADAWUL/9574

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tadawul/9574 stock rating?

tadawul/9574 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tadawul/9574 analysis?

The full report lives at /stocks/tadawul/9574/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tadawul/9574?

The latest report frames tadawul/9574 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tadawul/9574 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.